AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HT942523C0005TECHNOLOGY HOLDING LLC
Overview
Award facts
- Net obligations
- $1.10M
- $1,099,026of $1.10M potential value
- Period of performance
- Feb 27, 2023 to Jul 26, 2025
- Ended
- Modifications
- 1
- Latest action May 14, 2025
- Contract type
- Definitive contract
- PIID HT942523C0005
Description of requirement
AWARD OF R&D DHA PHASE II SBIR TO TECHNOLOGY HOLDING FOR PROJECT TITLED DEVELOPMENT OF HUMAN MONOCLONAL ANTIBODY THERAPEUTIC AGAINST KLEBSIELLA PNEUMONIAE INFECTION
Dates and value
- Award date
- Signed on Feb 22, 2023
- Potential end of performance
- Jul 25, 2025
- Current value
- $1,099,026Base and exercised options
- Potential value (if all options are exercised)
- $1,099,026
Obligations by fiscal year of action
- FY2023: $1,099,026
Total across 1 fiscal year: $1,099,026
The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 19, 2026 are not yet public.
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 14, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationWEST VALLEY CITY, UT
UEIU52NGYKN42H6
CAGE code5CTM1
Business sizeSmall businessSize at award, per the contracting officer
Parent companyTECHNOLOGY HOLDING LLC
Business types and certifications
For-profit organizationLimited liability company
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Defense
- Defense Health Agency
- ARMY MED RES ACQ ACTIVITY
- Funded by
- Department of Defense
- Defense Health Agency
- HQ MRDC - MM
Place of performance
- Place of performance
- West Valley City, Salt Lake County, Utah 84119-1441
- Congressional district (place of performance)
- UT-02As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- HQ003420RBDST(as reported)
- Solicitation date
- Sep 13, 2022
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Feb 22, 2023Base obligation at award: $1,099,026
- Latest action
- May 14, 2025 — Other administrative actionModification P00001; administrative: no change in scope or value
- Actions by type
- Base award1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Research program (SBIR/STTR)
- Small technology transfer research program phase iiST2
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- IT commercial item category
- Not IT products or servicesZ
- Awarding agency code
- 9700
- Awarding sub-tier code
- 97DH
- Contracting office code
- HT9425
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 9700
- Funding sub-tier code
- 97DH
- Funding office code
- HT0957